Everpure director sells shares valued at $10.8M
Two earlier sales of 70,000 shares each are labeled 10b5-1 sales, dated August 10 and September 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Everpure, Inc. (P) director and officer Charles Giancarlo reported a sale of 70,000 common shares with an aggregate market value of $10,814,300.00. The sale was executed on October 12, 2026; Morgan Stanley Smith Barney LLC was listed as broker and NYSE as the exchange. The shares came from restricted stock units that vested from September 20, 2019 through June 20, 2020. The transaction was reported on October 13 because EDGAR was not accepting filings on October 12 in observance of the federal holiday. Two earlier transactions were labeled 10b5-1 sales: 70,000 shares for $6,657,819.00 on September 10, 2026, and 70,000 shares for $6,925,793.00 on August 10, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 Sales regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.